ARNA insider filings

ARENA PHARMACEUTICALS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-03-11. Screen ARNA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ARNA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ARENA PHARMACEUTICALS INC

FiledFormInsiderReported transactionsSource
2022-03-114Knobil Katharine — DirectorOther (J): 2,939 · Other (J): 3,882 · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 7,202 (derivative)EDGAR
2022-03-114Nova Tina Susan — DirectorOther (J): 17,776 · Other (J): 3,067 · Disposition to issuer (D): 4,800 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 moreEDGAR
2022-03-114FETZER OLIVER — DirectorOther (J): 1,525 · Other (J): 8,167 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,167 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +3 moreEDGAR
2022-03-114GALLAHUE KIERAN — DirectorOther (J): 3,628 · Other (J): 1,116 · Other (J): 8,167 · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 4,583 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 moreEDGAR
2022-03-114Jarrett Jennifer — DirectorOther (J): 8,150 · Other (J): 3,067 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 moreEDGAR
2022-03-114NEIL GARRY ARTHUR — DirectorOther (J): 8,150 · Other (J): 3,067 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,167 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +3 moreEDGAR
2022-03-114Schoch Steven J — DirectorOther (J): 4,600 · Disposition to issuer (D): 3,601 (derivative) · Disposition to issuer (D): 7,202 (derivative)EDGAR
2022-03-114Dallas Jayson Donald Alexander — DirectorOther (J): 4,085 · Other (J): 3,067 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,167 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +3 moreEDGAR
2022-03-114Ouzren Nawal — DirectorOther (J): 890 · Other (J): 3,665 · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 1,666 (derivative) · Disposition to issuer (D): 7,202 (derivative)EDGAR
2022-03-114Manion Douglas J. — EVP Research & DevelopmentOther (J): 15,000 · Other (J): 21,462 · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 15,200 (derivative)EDGAR
2022-03-114Stelzer Laurie — EVP & Chief Financial OfficerOther (J): 9,086 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 132,000 (derivative) · Disposition to issuer (D): 38,850 (derivative) · Disposition to issuer (D): 15,200 (derivative)EDGAR
2022-03-114Munshi Amit — President and CEO, DirectorGift (G): 10,500 @ $98.51 · Other (J): 250 · Other (J): 28,800 · Other (J): 85,847 · Disposition to issuer (D): 138,139 (derivative) · Disposition to issuer (D): 56,861 (derivative) · +5 moreEDGAR
2022-03-114Schmidt Joan — EVP, General Counsel & SecOther (J): 8,165 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 132,000 (derivative) · Disposition to issuer (D): 38,850 (derivative) · Disposition to issuer (D): 15,200 (derivative)EDGAR
2022-03-114Aurentz Vincent — Executive VP and CBOOther (J): 27,842 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 77,000 (derivative) · Disposition to issuer (D): 94,976 (derivative) · +4 moreEDGAR
2022-03-114Lisicki Robert — EVP, Chief Commercial OfficerOther (J): 9,441 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 110,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · +2 moreEDGAR
2022-01-054Schmidt Joan — EVP, General Counsel & SecGrant/award (A): 21,462 @ $0EDGAR
2022-01-054Manion Douglas J. — EVP Research & DevelopmentGrant/award (A): 21,462 @ $0EDGAR
2022-01-054Munshi Amit — President and CEO, DirectorGrant/award (A): 85,847 @ $0EDGAR
2022-01-054Stelzer Laurie — EVP & Chief Financial OfficerGrant/award (A): 21,462 @ $0EDGAR
2022-01-054Lisicki Robert — EVP, Chief Commercial OfficerGrant/award (A): 21,462 @ $0EDGAR
2022-01-054Aurentz Vincent — Executive VP and CBOGrant/award (A): 21,462 @ $0EDGAR
2021-08-174Manion Douglas J. — EVP Research & DevelopmentGrant/award (A): 15,000 @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0EDGAR
2021-08-174Munshi Amit — President and CEO, DirectorPurchase (P): 1,000 @ $48.19EDGAR
2021-08-134Munshi Amit — President and CEO, DirectorPurchase (P): 1,000 @ $50.41EDGAR
2021-08-114Munshi Amit — President and CEO, DirectorPurchase (P): 1,000 @ $52.91EDGAR
2021-08-054Lisicki Robert — EVP, Chief Commercial OfficerOption exercise (M): 17,500 @ $40.95 · Sale (S): 5,605 @ $59.84 · Sale (S): 11,895 @ $60.20 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2021-06-154Knobil Katharine — DirectorGrant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-06-154Dallas Jayson Donald Alexander — DirectorGrant/award (A): 3,067 @ $0 · Sale (S): 1,223 @ $66.36 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-06-154GALLAHUE KIERAN — DirectorGrant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-06-154FETZER OLIVER — DirectorGrant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-06-154Ouzren Nawal — DirectorGrant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-06-154Nova Tina Susan — DirectorGrant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-06-154Jarrett Jennifer — DirectorGrant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-06-154Schoch Steven J — DirectorGrant/award (A): 1,533 @ $0 · Grant/award (A): 3,067 @ $0 · Grant/award (A): 3,601 (derivative) @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-06-154NEIL GARRY ARTHUR — DirectorGrant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2021-04-024Stelzer Laurie — EVP & Chief Financial OfficerOption exercise (M): 12,600 @ $0 · Tax withholding (F): 4,356 @ $76.10 · Option exercise (M): 12,600 (derivative) @ $0EDGAR
2021-04-024Schmidt Joan — EVP, General Counsel & SecOption exercise (M): 12,600 @ $0 · Tax withholding (F): 4,874 @ $77.58 · Option exercise (M): 12,600 (derivative) @ $0EDGAR
2021-03-034Schmidt Joan — EVP, General Counsel & SecGrant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0EDGAR
2021-03-034Lisicki Robert — EVP, Chief Commercial OfficerGrant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0EDGAR
2021-03-034Aurentz Vincent — Executive VP and CBOGrant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0EDGAR
2021-03-034Stelzer Laurie — EVP & Chief Financial OfficerGrant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0EDGAR
2021-03-034Munshi Amit — President and CEO, DirectorGrant/award (A): 28,800 @ $0 · Grant/award (A): 168,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0EDGAR
2021-02-184Ouzren Nawal — DirectorGrant/award (A): 893 @ $0 · Grant/award (A): 595 @ $0 · Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 1,666 (derivative) @ $0EDGAR
2021-02-184Aurentz Vincent — Executive VP and CBOOption exercise (M): 2,500 @ $14.60 · Option exercise (M): 24 @ $35.60 · Sale (S): 2,524 @ $85 · Option exercise (M): 2,500 (derivative) @ $0 · Option exercise (M): 24 (derivative) @ $0EDGAR
2021-02-044Lisicki Robert — EVP, Chief Commercial OfficerOption exercise (M): 17,500 @ $40.95 · Sale (S): 1,741 @ $77.70 · Sale (S): 6,400 @ $78.50 · Sale (S): 9,359 @ $79.35 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2021-02-044/ALisicki Robert — EVP, Chief Commercial OfficerHoldings only — no transactions reportedEDGAR
2021-01-204Dallas Jayson Donald Alexander — DirectorSale (S): 1,327 @ $80.50EDGAR
2021-01-204Munshi Amit — President and CEO, DirectorOption exercise (M): 50,000 @ $15.50 · Sale (S): 47,100 @ $80.19 · Sale (S): 2,900 @ $81.06 · Option exercise (M): 50,000 @ $15.50 · Sale (S): 50,000 @ $80.14 · Option exercise (M): 50,000 (derivative) @ $0 · +1 moreEDGAR
2021-01-144Munshi Amit — President and CEO, DirectorSale (S): 2,000 @ $73.90 · Sale (S): 7,481 @ $75.07 · Sale (S): 5,396 @ $75.64EDGAR
2021-01-114Munshi Amit — President and CEO, DirectorOption exercise (M): 23,400 @ $0 · Tax withholding (F): 8,523 @ $77.59 · Option exercise (M): 23,400 (derivative) @ $0EDGAR

Recent 8-K events — ARENA PHARMACEUTICALS INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-03-118-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-108-K8.01 — Other EventsEDGAR
2022-02-238-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-02-078-K8.01 — Other EventsEDGAR
2022-02-028-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2022-01-078-K8.01 — Other EventsEDGAR
2021-12-138-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-06-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ARNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs